Medications

Is a cancer pill a matter of time?

A cancer pill, preferably without severe side effects, is something we'd all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves ...

Health informatics

New AI technology sheds light on drug development

Will artificial intelligence (AI) change the traditional trial–and–error drug development process and become a revolutionary force in the pharmaceutical sector? Active learning and interpretable AI are the two critical ...

Medications

Developing drugs with the aid of artificial intelligence

Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that can help make drug design cheaper and faster. His Ph.D. defense is on 15 ...

Neuroscience

Novel study aims to help kids with severe epilepsy

New research from the University of South Australia could deliver a breakthrough for children suffering one of the most severe forms of genetic epilepsy, reducing the frequency of their seizures and improving their quality ...

Medications

New data on drug metabolism and distribution in the eye

Severe visual illnesses are increasing in our society, and effective treatments are missing for diseases as age-related macular degeneration, diabetic retinopathy, and glaucoma. Both industry and academia are highly interested ...

page 22 from 40